Microbix Biosystems Inc. (MBX)

Toronto
Currency in CAD
0.30
-0.01(-3.23%)
Closed·
MBX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MBX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.300.31
52 wk Range
0.290.55
Key Statistics
Edit
Bid/Ask
0.30 / 0.32
Prev. Close
0.31
Open
0.31
Day's Range
0.3-0.31
52 wk Range
0.29-0.55
Volume
20.57K
Average Volume (3m)
79.82K
1-Year Change
-10.45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MBX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.50
Upside
+66.67%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Microbix Biosystems Inc. News & Analysis

Show more

Microbix Biosystems Inc. Company Profile

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Employees
100
Market
Canada

Microbix Biosystems Inc. Earnings Call Summary for Q2/2025

  • Q2 revenue of $5.32M missed forecast by 22.9%, leading to a 5.56% stock price drop
  • Gross margins improved to 60%, up 7% YoY; net earnings for first half at $900,000
  • Cash position strengthened to $2.7M through warrant/option exercises
  • Company anticipates weaker sales in latter half of fiscal year, particularly in test ingredient sales
  • Focus on strategic client acquisition in CAPS business; Kinlytic drug development aims for FDA re-approval by 2027
Last Updated: 15/05/2025, 17:58
Read Full Transcript

Compare MBX to Peers and Sector

Metrics to compare
MBX
Peers
Sector
Relationship
P/E Ratio
27.8x−5.1x−0.5x
PEG Ratio
−0.44−0.010.00
Price/Book
1.4x−3.5x2.6x
Price / LTM Sales
1.9x1.3x3.0x
Upside (Analyst Target)
61.3%160.9%52.6%
Fair Value Upside
Unlock7.9%8.8%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.50
(+66.67% Upside)

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-- / --
Revenue / Forecast
5.32M / 6.90M
EPS Revisions
Last 90 days

FAQ

What Is the Microbix Biosystems Inc. (MBX) Share Price Today?

The live Microbix Biosystems Inc. share price today is 0.30.

What Stock Exchange Does Microbix Biosystems Inc. (MBX) Trade On?

Microbix Biosystems Inc. is listed and trades on the Toronto Stock Exchange stock exchange.

What Is the Ticker (Stock Symbol) for Microbix Biosystems Inc.?

The stock symbol (also called a 'ticker') for Microbix Biosystems Inc. is "MBX."

What Is the Current Microbix Biosystems Inc. Market Cap?

As of today, Microbix Biosystems Inc. market capitalisation is 42.17M.

What Is Microbix Biosystems Inc.'s (MBX) Earnings Per Share (TTM)?

The Microbix Biosystems Inc. EPS 0.01 (Trailing Twelve Months).

When Is the Next Microbix Biosystems Inc. Earnings Date?

Microbix Biosystems Inc.'s next earnings report will be released on 12 Aug 2025.

Is MBX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Microbix Biosystems Inc. moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Microbix Biosystems Inc. Stock Split?

Microbix Biosystems Inc. has split 0 times. (See the MBX stock split history page for full effective split date and price information.)

How Many Employees Does Microbix Biosystems Inc. Have?

Microbix Biosystems Inc. currently has 100 employees.

What is the current trading status of Microbix Biosystems Inc. (MBX)?

As of 21 Jun 2025, Microbix Biosystems Inc. (MBX) is trading at a price of 0.30, with a previous close of 0.31. The stock has fluctuated within a day range of 0.30 to 0.31, while its 52-week range spans from 0.29 to 0.55.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.